eBook - ePub
Perspectives in Behavioral Medicine
Eating Regulation and Discontrol
Herbert Weiner,, Andrew S. Baum,, Herbert Weiner,, Andrew S. Baum,
This is a test
Share book
- 248 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Perspectives in Behavioral Medicine
Eating Regulation and Discontrol
Herbert Weiner,, Andrew S. Baum,, Herbert Weiner,, Andrew S. Baum,
Book details
Book preview
Table of contents
Citations
About This Book
First published in 1987. Routledge is an imprint of Taylor & Francis, an informa company.
Frequently asked questions
How do I cancel my subscription?
Can/how do I download books?
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
What is the difference between the pricing plans?
Both plans give you full access to the library and all of Perlegoâs features. The only differences are the price and subscription period: With the annual plan youâll save around 30% compared to 12 months on the monthly plan.
What is Perlego?
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Do you support text-to-speech?
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Is Perspectives in Behavioral Medicine an online PDF/ePUB?
Yes, you can access Perspectives in Behavioral Medicine by Herbert Weiner,, Andrew S. Baum,, Herbert Weiner,, Andrew S. Baum, in PDF and/or ePUB format, as well as other popular books in Psychology & History & Theory in Psychology. We have over one million books available in our catalogue for you to explore.
Information
1
REGULATION OF GASTRIC SECRETIONâNEURAL MECHANISMS
The importance of neural mechanisms in the regulation of gastric secretion has passed through at least three cycles. In Pavlovâs time, nerves were considered to be of primary importance as demonstrated in conscious dogs with esophagostomies (sham feeding) and in the comparison of the responses of vagally innervated (Pavlov) gastric fundic pouches to those of vagally denervated (Heidenhain) pouches. Then came the pioneering experiments of Bayliss and Starling and Edkins in the role of hormonal regulation, culminating in the purification and isolation of gastrin by Gregory and his associates. Hormones became the dominant factors, including hormones released by nerve stimulation (e.g., gastrin). We are now in a third phase in which the same substance may play a role in the regulation of gastric secretion as a classical hormone, a neurotransmitter, a neuromodulator, and a paracrine messenger.
I have reviewed the subject on several occasions in the past (Brooks, 1965, 1967, 1968, 1975, 1977, 1981). The number of publications on the subject has increased substantially recently, as indicated by the approximately 20 related abstracts submitted for presentation during Digestive Disease Week in 1985. In this review, I will consider nervous regulation of gastric exocrine and endocrine secretion by nerves within the wall of the stomach, by extrinsic nerves, and by the brain.
INTRAMURAL NERVOUS CONTROL
Structure
The structural basis for the innervation of secretory cells in the stomach is still incompletely understood. Light microscopic studies show bare nerve endings in close contact with parietal cells in rabbits (Hanker, Tapper, & Ambrose, 1977). In the cat, nerve endings reached only the basal half of the fundic glands (Kyosola, Veyola, & Richardt, 1975). More recently, electron micrographs showed no nerve axons or varicosities closer than 100 nM to parietal cells in the opossum (Seelig, Schlusselberg, & Woodward, 1983); and similar findings have been reported for rat mucosal epithelial cells (Crocket, Doyle, & Joffee, 1981) and rhesus monkey parietal cells (Lechago & Barajas, 1976). The latter were stained for acetylcholinesterase. It is interesting that in salivary glands an electrical intracellular response to single parasympathetic nerve impulses was seen only when the gap between nerve endings and secretory cells was about 20nM (Garrett, 1974). Cholinergic nerve endings have also been demonstrated in contact with gastrin cells (Lechago & Barajas, 1981).
Recent immunohistochemical studies have identified regulatory peptides such as substance P, vasoactive intestinal polypeptide (VIP), enkephalins, and the gastrin-cholecystokinin (CCK) peptides near gland cells. Cell bodies in the myenteric plexus of the stomach contained immunoreactive substance P, VIP, and enkephalins (Schultzberg et al., 1980). The submucosal plexus is poorly developed in the stomach. Gastrin-releasing polypeptide is reported to be present in nerve endings in the pyloric antrum. Nerve endings with vesicles consistent with neuropeptides have been found within 200â300 nm of gastrin cells (Lechago & Barajas, 1981).
Cellular Physiology of H+ Secretion
The development of relatively pure parietal and chief cell preparations has made it possible to examine the role of neurotransmitters acting on gastric secretory cells. Acetylcholine stimulated the accumulation of acid in the canaliculi of isolated parietal cells. The effect was blocked by atropine (Soll, 1980). Saturable, temperature-dependent binding of [3H]QNB(Quinuclidinyl benzilateâan anticholinergic), to rat parietal cells in vitro has been demonstrated, which is consistent with the presence of cholinergic receptors (Ecknauer, Thompson, Johnson, & Rosenfeld, 1980). The second messenger in stimulus-secretion coupling appears to be calcium, rather than cyclic AMP (Soll, 1981).
The accumulation of H+ in parietal cells in response to acetylcholine, histamine, or gastrin was blocked by H2 antagonists such as cimetidine (Soll, 1981). There are two hypotheses to account for this: one, proposed by Soll, is based on potentiation between receptors for the three stimulants (Soll, 1982); the other proposes that acetylcholine and gastrin release histamine (Lorenz, Mohri, Reimann, Troidl, Rohde, & Barth, 1980). In non-rodent mammals, the mucosal source of histamine appears to be a mastlike cell (Lorenz, Thon, Barth, Neugebauer, Reimann, & Kusche, 1983). Histamine release in response to nerve stimulation has yet to be established. Figure 1.1 shows the interactions between receptors on the parietal cell, while Figure 1.2 illustrates the role of histamine as a common mediator.
A calcium-calmodulin complex in the parietal cell may determine levels of calcium-dependent protein kinases which are thought to influence the availability of potassium ions for the exchange of H+ for K+ at the canalicular membrane, powered by the H+ âK+ ATPase or proton pump (Walker, Vinik, Heldsinger, & Kaveh, 1983).
Similar results have been obtained with isolated fundic glands (Berglindh, 1977). It is interesting that glands from human stomachs after vagotomy accumulated H+ at a reduced sensitivity to both histamine and carbachol (Leth, Elander, Fellenius, Haglund, & Olbe, 1981).
Nervous Stimulation of Acid Secretion in the Isolated Stomach
Electrical field stimulation of the isolated mouse stomach stimulated acid secretion. It was blocked by tetrodotoxin and reduced by atropine and hexamethonium, a ganglionic cholinergic blocker (Angus & Black, 1978). Mucosal preparations from rat stomach responded similarly (Baird & Main, 1978). These results are consistent with stimulation of acid secretion by cholinergic neurons in the myenteric plexus.
Pepsinogen and Intrincis Factor Secretion
Rabbit gastric mucosa in organ culture responded to acetylcholine by increasing secretion of pepsinogen and intrinsic factor. The effect was blocked by atropine (Kapadia & Donaldson, 1978). In the isolated fundic gland preparation from rabbits, both acetylcholine and the β-adrenergic agonist isoproterenol stimulated the release of pepsinogen in a dose-related manner. Isoproterenol was without effect on gastric acid secretion (Koelz, Hersey, Sachs, & Chew, 1982). The formerâs effect was blocked by atropine and the latter by propranolol. Cholinergic binding sites on chief cells in isolated gastric glands have been demonstrated with QNB (Culp, Wolosin, Soll, & Forte, 1983). Similar results were obtained with canine chief cells in primary monolayer culture (Sanders, Amirian, Ayalon, & Soll, 1983).
Alkaline Secretion from Surface Epithelial Cells of the Stomach
Amphibian gastric fundic mucosa secrete bicarbonate actively in vitro in response to carbachol (Flemstrom, 1977). This appears to be the result, in part, of a chloride-bicarbonate exchange at the luminal membrane (Flemstrom & Garner, 1982).
Cholinergic and Adrenergic Control of Secretion in Vivo
Cholinergic and adrenergic transmitters can be given by close intra-arterial or by intravenous injection to determine the pharmacologic actions of these agents. On the other hand, anticholinergics or antiadrenergic drugs can be given by a variety of routes and the extent to which they inhibit nerve-mediated secretion determined. Stable analogues of acetylcholine are potent stimulants of acid secretion in animals but not in man. Beta-adrenergic agonists given intravenously stimulate acid secretion, probably secondary to the release of gastrin (Geumei, Issa, El-Gendi, & Abd-El-Samie, 1969).
The secretion of a bicarbonate-rich fluid with an otherwise similar composition to an ultrafiltrate of plasma can be obtained in dogs after the close intra-arterial injection of acetylcholine (Altimirano, 1963). Mucus secretion was also stimulated (Flemstrom, 1977).
Gastrin and Somatostatin Secretion
Antral mucosa from rats in organ culture released immunoreactive gastrin into the medium in response to carbachol in a dose-related manner (Harty & McGuigan, 1980). It was blocked by atropine. The incorporation of 3H-tryptophane into gastrin also increased in response to carbachol (Harty & McGuigan, 1980). At the same time, the release of somatostatin was reduced by carbachol. The presence of antibodies to somatostatin increased the gastrin released in response to carbachol by 69% (Wolfe, Reel, & McGuigan, 1984). Somatostatin reduced carbachol-induced release of gastrin (Harty, Maico, & McGuigan, 1981). Both norepinephrine and isoproterenol released gastrin and inhibited the release of somatostatin, suggesting parallel cholinergic and β-adrenergic control of gastrin and somatostatin release (Spindel, Harty, & McGuigan, 1984).
Gastrin-releasing peptide (GRP) released gastrin in this preparation. GRP appears to mediate gastrin release in response to β-adrenergic stimulation (Wolfe, Reel, Short, & McGuigan. 1984). Gamma-aminobutyric acid (GABA) released gastrin apparently by releasing acetylcholine from nerve endings (Harty & Franklin, 1983). Adenosine, on the other hand, inhibited the release of gastrin in response to carbachol (Harty & Franklin, 1984). However, carbachol had no effect on gastrin secretion by isolated canine antral mucosal cell cultures (Sugano, Park, Soll, & Yamada, 1984).
Use of the whole stomach in vitro permits a clear distinction between secretion into the vascular compartment and release into the lumen. Gastrin secretion by isolated perfused rat stomachs was increased by methacholine. Seventy-nine percent was secreted into the venous effluent and 21 % into the lumen. The effect was blocked by atropine. The secretion of somatostatin was reduced in a reciprocal fashion (Saffouri, Weir, Bitar, & Makhlouf, 1980). Bombesin released gastrin and somatostatin into the venous effluent. Figure 1.3 shows a proposed model for the nervous control of gastrin and somatostatin secretion (Du Val, Saffouri, Weir, Walsh, Arimura, & Mahklouf, 1981). There is controversy over the role of ganglionic receptors in the cholinergic control of gastrin and somatostatin secretion. One group of investigators reported that nicotinic receptor stimulation caused the secretion of both gastrin and somatostatin. Atropine completely blocked only the latter (Schubert & Makhlouf, 1982). An antiserum to bombesin reduced gastrin release by two thirds in response to a nicotine ganglionic agonist (Schubert, Walsh, & Makhlouf, 1983). The other group found that hexamethonium, a nicotinic receptor blocker, had no effect on bombesininduced gastrin release but blocked the release of somatostatin. They concluded that no ganglionic receptors were involved in carbacholine-induced release of gastrin or the inhibition of somatostatin release (Martindale, Kauffman, Levin, Walsh, & Yamada, 1982).